US44934S2068 - Common Stock
ICAD INC
NASDAQ:ICAD (5/2/2024, 7:00:03 PM)
After market: 1.49 0 (0%)1.49
+0.06 (+4.2%)
iCAD, Inc. is a global medical technology company, which engages in the provision of cancer detection and therapy solutions. The company is headquartered in Nashua, New Hampshire and currently employs 109 full-time employees. The firm is focused on providing breast cancer detection solutions built on artificial intelligence (AI) that empowers radiologists to find cancers. Its solutions include advanced image analysis and workflow solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing the most prevalent cancers earlier, and a range of high-performance, AI and computer-aided detection (CAD) systems and workflow solutions for 2D and 3D mammography, magnetic resonance imaging and computed tomography (CT). The Company’s Breast AI Suite offers a triple threat of clinically proven cancer detection, density assessment, and risk evaluation solutions, designed to accelerate discovery and improve outcomes. The company also offers ProFound AI, a digital breast tomosynthesis (DBT) cancer detection and workflow solution.
ICAD INC
98 Spit Brook Rd Ste 100
Nashua NEW HAMPSHIRE 03062
P: 16038825200
CEO: Michael Klein
Employees: 109
Website: https://www.icadmed.com/
NASHUA, N.H., May 02, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global leader in clinically proven AI-powered cancer detection solutions,...
ProFound Cloud, powered by Google Cloud architecture and Google’s Health AI innovations, redefines accessibility to critical insights, empowering...
Provides a holistic breast health solution, including breast cancer screening focused on quality, safety and efficiency, breast cancer detection, breast...
Study confirms iCAD’s Breast Arterial Calcification AI Algorithm successfully detects calcification of breast vessels, an indicator of cardiovascular...
ProFound Cloud redefines accessibility to critical insights, empowering radiologists in early breast cancer detection...
These AI stocks will get big boosts from the proliferation of AI over the longer term, but the market is not giving them enough love.
Here you can normally see the latest stock twits on ICAD, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: